SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Chemical Name: 4-Amino-5-fluoro-1-(2,3-di-O-acetyl-α-D-ribofuranosyl)-2(1H)-pyrimidinone
Synonym: Capecitabine α-Isomer Diacetyl Impurity
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: O=C1N=C(N)C(F)=CN1[C@@H]2[C@@H]([C@@H]([C@@H](CO)O2)OC(C)=O)OC(C)=O
Capecitabine α-Isomer Diacetyl Impurity is chemically 4-Amino-5-fluoro-1-(2,3-di-O-acetyl-α-D-ribofuranosyl)-2(1H)-pyrimidinone. It is also known as Capecitabine α-Isomer Diacetyl Impurity. Capecitabine α-Isomer Diacetyl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Capecitabine α-Isomer Diacetyl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Capecitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, Shailesh
From American Journal of PharmTech Research (2020), 10(6), 115-133
Validated stability indicating HPLC method for estimation of capecitabine
By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N.
From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658
RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67